Seroprevalence of human cytomegalovirus antibodies among children with type I diabetes mellitus in the Aseer Region, Southwest KSA  by Al-Hakami, Ahmed M. et al.
Taibah University
Journal of Taibah University Medical Sciences (2016) 11(4), 388e394Journal of Taibah University Medical Sciences
www.sciencedirect.comOriginal ArticleSeroprevalence of human cytomegalovirus antibodies among
children with type I diabetes mellitus in the Aseer Region, Southwest
KSA
Ahmed M. Al-Hakami, PhD a, Ayed A. Shati, MD c, Ali M. Alsuheel, MD c,
Abdulrahim R. Hakami, MSc b, Mohammad A. Al Qahtani, MDd,
Hessa M. Jelban, MD c and Abdelwahid S. Ali, PhD a,*
aDepartment of Microbiology and Clinical Parasitology, College of Medicine, King Khalid University, Abha, KSA
bDepartment of Medical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, KSA
cDepartment of Paediatrics, College of Medicine, King Khalid University, Abha, KSA


























.ﻯﺮﺧﻷﺍﻖﻃﺎﻨﻤﻟﺍﻝﺎﻔﻃﺄﺑﺔﻧﺭﺎﻘﻣﻰﻠﻋﺃﺐﺴﻨﺑﻱﺮﺸﺒﻟﺍCorresponding address: Department of Microbiology and
nical Parasitology, College of Medicine, King Khalid University,
. Box 641, 61421 Abha, KSA.
E-mail: abumalaz2002@gmail.com (A.S. Ali)
r review under responsibility of Taibah University.
Production and hosting by Elsevier
8-3612  2016 The Authors.











Objectives: This study is aimed at determining the sero-
prevalence and possible infectivity factors of human
cytomegalovirus (HCMV) in children affected by type 1
diabetes mellitus (T1DM) in the Aseer Region of KSA.
Methods: A total of 205 children diagnosed with T1 DM
who routinely attended the Diabetic Centre (DC) of
Aseer Central Hospital (ACH) in Abha KSA were
randomly selected. Another control group of 51 non-
diabetic children were also selected. Sera of both groups
were tested for HCMV-specific IgG and IgM using an
indirect enzyme linked immune-sorbent assay (ELISA).
Results: The recorded HCMV-IgG seroprevalence rates
were found to be higher in both groups of children than
the IgM responses, which were consistently low. There
were no obvious differences between the two groups iny. This is an open access article under the CC BY-NC-ND license
.1016/j.jtumed.2016.01.001
A.M. Al-Hakami et al. 389terms of HCMV responses. No significant variations were
observed between girls and boys in terms of the sero-
prevalence rates. The highest positive IgG prevalence
rates to HCMV were observed among 11- to 15-year-old
children, and the least positive rates were noted in chil-
dren younger than 5 years of age. Children from Abha
city and its vicinity showed relatively higher HCMV-
specific IgG and IgM responses rates than children
from other localities.
Conclusions: Despite the presence of high HCMV-IgG
response rates among the studied group of children, this
study could not identify the associated clinical manifes-
tations. There is no correlation between T1 DM and virus
infectivity, as this research could not find differences in
serological responses to the virus between the diabetic
and non-diabetic children.
Keywords: ELISA; HCMV; IgG; IgM; Type 1 diabetes
mellitus
 2016 The Authors.
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NC-ND license (http://creativecommons.org/licenses/by-nc-
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Human cytomegalovirus (HCMV) is a b-herpes virus that
was first isolated in 1957.1 HCMV, also known as human
herpes virus-5 (HHV-5), is a member of the family Herpes-
viridae, sub-family Betaherpesvirinae, genus Cytomegalo-
virus.2,3 The HCMV virion is characterized by a 235 kb,
double stranded, linear DNA genome enclosed in an
icosahedral capsid protein surrounded by a proteinaceous
tegument and an outer lipid envelope.4
HCMV is a widespread infectious agent that infects the
majority of the world population by early adulthood.5 Cases
of HCMV have been recognized in all geographic locations
and socioeconomic groups of people. It has been
documented in some reports that HCMV infects between
50% and 85% of the adult population in Central Europe
and the USA.6,7
HCMV is often associated with the salivary glands.3
HCMV is transmitted through direct contact with an
infected person’s body secretions, including saliva, semen,
urine and breast milk.8 Blood transfusion and organ
transplants are also potential means of HCMV
transmission.8,9 HCMV can also be transmitted from
mother to child, either prenatally or perinatally.10
Primary infections of HCMV in healthy individuals are
clinically inapparent.11 Following the primary infection,
HCMV can remain latent within the body for a long
period.12 However, in persons with an immature or weak
immune system, the latent HCMV can be reactivated,
resulting in high morbidity and mortality rates.13
Symptoms include spiking fever, leucopenia, malaise,
hepatitis, pneumonia, gastrointestinal disorders and
retinitis.11 HCMV has also been reported to be responsible
for 8% of infectious mononucleosis cases worldwide.14 It isalso considered to be the leading viral cause of birth
defects, such as deafness and neurodevelopment delay, in
newborns.15 The serological tests that were employed to
the measure the CMV-specific antibodies were also
designed to differentiate between past and recent exposure to
the virus. CMV-specific IgM antibodies appear early after
the virus exposure and last for approximately two weeks,
whereas CMV-specific IgG antibodies appear 10e14 days
later and remain for life.16
It is well-established in the medical literature that viruses
are potential environmental factors that induce autoimmu-
nity in T1DM.17 Viral infections that have been associated
with increased risk of T1DM in children include
enteroviruses,18,19 rubella virus,20,21 mumps,22 measles,23
EpsteineBarr virus,24 varicella zoster virus,25
retroviruses,26 rotavirus27 and cytomegalovirus.28
The possible mechanisms of HCMV-induced b-cell dam-
age were found to be either through apoptotic effects,29e31
cytotoxic effects32 or via induction of cytokines in the
infected b-cells.33
The worldwide incidence of T1DM has seen an approxi-
mately 400-fold increase in recent years.34 The incidence and
prevalence of T1DM in children in different locations in
KSA has been reported in several previous studies.35,36 The
incidence of T1DM has increased annually in the kingdom
at large and in the Aseer Region in particular.37 Moreover,
KSA is ranked among the countries with the highest
frequency levels of diabetic ketoacidosis (DKA) at first
presentation of T1DM in children.38 Despite the fact that
other T1DM environmental inducing factors and HCMV
epidemiology have previously been studied, this is the first
study aimed at correlating and investigating the role of
viral infections in the development of T1DM in the KSA.
Materials and Methods
Patient selection
A total of 205 diabetic children who routinely attended
the Diabetes Centre in Aseer Central Hospital in Abha,
Southwest KSA, were randomly selected. The participants
had already been diagnosed as T1DM patients using clinical
and laboratory investigations. Patients targeted ranged from
1 to 18 years old, included both genders (M/F) and came
from various geographic localities in the area. The control
group contained 51 children who were non-diabetic (in the
same age range) and attended the same paediatric clinics in
the hospital as the first group. A consent form was completed
before sampling the patients. General information (e.g.,
name, age, gender, residence, age at diagnosis, history of
blood transfusion, consanguinity, initial presentation of
DKA or hyperglycaemia and associated diseases such as
hypothyroidism, celiac disease, and vitiligo) and diabetes-
related information (e.g., random blood sugar, HbA1C,
and TFT) were recorded for each of the targeted patients.
Sampling procedure and processing
Blood sampling was completed in accordance with the
WHO guidelines for paediatric and neonatal blood sam-
pling.39 Between 2 and 3 ml of venous blood was collected in
Seroprevalence of HCMV in diabetics390an evacuated tube from each child. The blood was then
preserved at room temperature for 2e3 h before the sera
were separated. The sera were then stored at 20 C before
CMV-specific antibody testing was conducted.HCMV-specific IgG and IgM testing
To determine the children’s recent or previous exposure to
the virus, sera were tested for both HCMV-IgG and IgM
antibodies using the well-established indirect ELISA. ELISA
was employed as described by the manufacturer (Human
Gesellschaft fur Biochemica und Diagnostic mbH, Wiesba-
den, Germany). Micro-well plates coated with the purified
CMV antigen were used. Diluted patient sera were added to
the plate wells and incubated at 37 C for one hour to
facilitate binding between the HCMV antigens and the an-
tibodies (if present). Unbound components were then
washed. Anti-human IgG and IgM conjugate were then
added and incubated as previously described. The plate was
then washed to remove the excess conjugate and a solution of
TMB reagent as a colour substrate was added. The enzyme
conjugate catalytic reaction was stopped at a specific time.
The absorbance of both the test and control sera was
determined by using the automated ELISA microwell reader
(HUMAN’s HumaReader). The results were obtained by
comparing the absorbance in a parallel manner with cali-
brators and controls. A software computer system was used
to determine the cut-off points and consequently the positive
reaction was determined compared to the control sera.Statistical analysis
The statistical significance of differences between groups
of data was determined using the two-tailed Student’s un-
paired t-test.Results
Total HCMV serological responses
The total seroprevalence rates of HCMV-specific IgG and
IgM in both groups of children are shown in Table 1.
Generally, the HCMV-specific IgG rates were higher in
both groups of children than the HCMV-specific IgM.
Following a systematic individual search of the results, a
total of 202 children were found to test positive for HCMV-
IgG but negative for IgM (in both groups). It was also
observed that all children who tested positive for HCMV-
IgM (in both groups) were also positive for HCMV-IgG
with only one exception being a diabetic child.Table 1: Total seroprevalence rates of HCMV-specific IgG and IgM
Diabetic children
Positive (%) Negative (%) To
CMV-specific IgG 165 (80.5)a 40 (19.5) 205
CMV-specific IgM 13 (6.3) 192 (93.7) 205
a Number (percentage) of children.HCMV serological responses in both genders of children
The HCMV serological response rates in both groups of
children for both genders (M & F) are listed in Table 2.
Generally, no significant variation between the male and
female children could be observed in the serological
responses to HCMV in both groups.
HCMV serological responses in different age groups of
children
The serological response rates to HCMV in both groups
of children at different ages are shown in Table 3. The results
reveal that children 11e15 years old had the highest positive
IgG responses to HCMV, while those younger than 5 years
old showed the lowest HCMV-IgG responses. As for the
HCMV-IgM responses, an opposite trend was observed,
with the results showing that the response rates were higher
in the younger groups of children and lower in the older
groups.
HCMV serological responses for diabetic children from
different localities
Table 4 demonstrates the HCMV-IgG and HCMV-IgM
responses of diabetic children from different localities in the
study area. Generally, theAbha andKhamisMushait regions
showed the highest prevalence rates for both HCMV-specific
IgG and IgM responses, whereas the regions of Belahmer, Al-
Wadein and Al-Namas showed the lowest rates.
Discussion
HCMV was chosen to examine the relationship between
infectivity and T1DM in children in the Aseer Region for
three reasons: First, there is a highly possible means of virus
transmission in the area; second, there is no vaccine for
HCMV, and hence, a positive seroconversion indicates pre-
vious exposure to the virus; and third, the role of HCMV in
the autoimmune T1DM development has been previously
confirmed,23,28,29 and thus, an association between the two
complications was much more probable.
The findings showed high HCMV-specific IgG response
rates in both groups of children, with non-significant varia-
tions, whereas the HCMV-specific IgM rates were always
lower. This indicates that most of the children in the study
area were exposed to the virus in the past and that recent
infection is less probable. This is logically true and is
compatible with previous findings in other parts of the
world.40 The results also showed that many children tested
positive for HCMV-IgG and negative for IgM. They werein diabetic and non-diabetic children.
Non-diabetic children
tal (%) Positive (%) Negative (%) Total (%)
(100) 44 (86.3) 7 (13.7) 51 (100)
(100) 9 (17.6) 42 (82.4) 51 (100)
Table 2: Seroprevalence rates to HCMV in both genders of children.
Diabetic children Non-diabetic children
Male Female Total Male Female Total
CMV-specific IgG 83 (50.3)a 82 (49.7) 165 (100) 23 (52.3) 21 (47.7) 44 (100)
CMV-specific IgM 8 (61.5) 5 (38.5) 13 (100) 6 (66.7) 3 (33.3) 9 (100)
a Number (percentage) of positive children to HCMV-IgG and HCMV-IgM.





Diabetic children Non-diabetic children
HCMV-IgG HCMV-IgM HCMV-IgG HCMV-IgM
1e5a 6 (3.6)* 6 (46.2) 3 (6.8) 5 (55.6)
6e10b 44 (26.7) 4 (30.7) 16 (36.4) 2 (22.2)
11e15c 77 (46.7) 3 (23.1) 20 (45.4) 2 (22.2)
16e18d 38 (23.0) 0 (00.0) 5 (11.4) 0 (00.0)
Total
(%)**
165 (80.5) 13 (6.3) 44 (86.3) 9 (17.6)
*Number (%) of children who tested positive.
**Total number of children tested positive and the percentage is
calculated from the total number of children tested positive in
each group as in Table 1.
a, b, c and d indicates children before or pre-school, primary
school, intermediate school and high school, respectively.
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with body fluids (e.g., saliva) from infected persons. Intra-
uterine infection was also a possibility because none of the
children recorded having experienced a blood transfusion.
The children who tested positive for HCMV-IgM were
probably infected with the virus a few weeks before the study
because there is no vaccine. These children, when observedTable 4: HCMV-serological response rates in diabetic children





Abha 62 (37.5)a 6 (46.1)b
Khamis Mushait 37 (22.3) 2 (15.4)
Mahayl 30 (18.1) 0 (00.0)
Rejal alma 9 (5.4) 1 (07.7)
Bish 5 (3.0) 0 (00.0)
Belasmer 5 (3.0) 0 (00.0)
Dhahran Al-Janoub 6 (3.5) 1 (07.7)
Jazan 4 (2.4) 2 (15.4)
Al-Namas 2 (1.2) 0 (00.0)
Najran 3 (1.8) 1 (07.7)
Al-Wadein 2 (1.2) 0 (00.0)
Belahmer 1 (0.6) 0 (00.0)
Totalc 165 (100) 13 (100)
a Number (percentage) of diabetic children tested positive of
CMV-IgG.
b Number (percentage) of diabetic children tested positive of
CMV-IgM.
c Total number (percentage) of diabetic children tested positive
in all localities.clinically, did not appear to be suffering from a disease, and
consequently, an asymptomatic infection was supposed, as
asymptomatic infection of HCMV is well documented in
previous reports.41
It is also noted that all children who tested positive for
HCMV-IgM (in both groups) were also positive for HCMV-
IgG with the exception of only one diabetic female child (13
years old). It is suggested that this child was exposed to the
virus recently. This child showed no apparent clinical man-
ifestations of the virus infection, but symptoms related to
T1DM (such as hyperglycaemia and elevated HbA1C) were
recorded. This substantiates the association of the asymp-
tomatic HCMV infection with T1DM development in
children.28
Having observed that a high number of diabetic children
had positive IgG responses to the virus, we thought an as-
sociation between the virus infectivity and T1DM develop-
ment might exist. That hypothesis was logical, as the
association of the two disorders had been confirmed in
multiple previous reports.42e44 However, when similar high
levels of IgG responses were also observed in the non-
diabetic children, we concluded that an association is less
possible. This finding is in disagreement with that reported
by Roberts and Cech (2005),45 who confirmed a usual
collinearity of trends between diabetes and seropositivity
for HCMV.
Diabetic children who showed negative serological re-
sponses to HCMV are supposed to have T1DM induced by
environmental factors other than HCMV infectivity. Many
contributing factors have been addressed previously to
correlate the risk factors to the increase in T1DM. Example
of factors that have been addressed are the early introduction
of cow’s milk, milk formulae and vaccinations46; maternal
age at birth, birth order and birth weight47; and viruses
other than HCMV.
Our findings also showed no significant variation between
male and female children in the HCMV serological re-
sponses. This is similar to previous studies in which gender
did have much effect on HCMV infectivity.48 However, in
another similar study carried out by Redwan et al. (2011)49
among the adult population in Jeddah (West region of
KSA) showed that CMV seroprevalence differed
significantly by sex and was higher in females than in males.
Children aged 11e15 years showed the highest positive
IgG response rates to HCMV. This signifies that more
attention to preventive care should be given to the interme-
diate aged school children in the study area. Children from 1
to 5 years old (before or at pre-school level) showed the
lowest HCMV-IgG responses. Similar findings were reported
by Stephanie et al. (2006),50 who noted that the prevalence of
HCMV is lower in children younger than 6 years but
increased gradually with age. Similar trends were also
Seroprevalence of HCMV in diabetics392noted by Redwan et al. (2011)49 and Dollard et al. (2011).51
In contrast to HCMV-IgG, the HCMV-IgM responses were
usually higher in children less than 5 years old and decreased
with age. This indicates that children are exposed to the virus
in the study area during early childhood and gain a detect-
able HCMV-specific immunity with age.
The serological responses for HCMV in children origi-
nating from different localities in the study area were also
examined. Among the localities, children from the city of
Abha and the surrounding vicinity showed relatively higher
HCMV seroprevalence rates. In KSA, HCMV infectivity
was previously studied in various regions of the country for
both children and adult populations.49,52,53 However, this is
the first report to determine HCMV infectivity in the
southern region of the country and particularly among
T1DM affected children.
It is also worth mentioning that the criteria for the diag-
nosis of T1DM and HCMV infection are completely
different, and thus, the relationship between the two com-
plications may not be easily determined. However, we
adopted the generally accepted guidelines for the correlation
between the two conditions recommended in previous
studies.54,55
Conclusions
High HCMV seroprevalence rates in children in the study
area were recorded. No obvious differences in HCMV-
serological responses between the diabetic and non-diabetic
children were observed. No significant variation between
male and female children in terms of the seroprevalence of
HCMV in both groups was noted. Children from 11 to 15
years old showed the highest HCMV-IgG prevalence rates,
while those younger than 5 years old showed the lowest rates.
Diabetic children from the Abha and Khamis Mushait areas
had the highest HCMV-seroprevalence rates, while those
from Belahmer, Al-Wadein and Al-Namas had the lowest
rates.
Recommendations
Given the number of children that showed high positive
seroprevalence rates of HCMV in the study area, we
recommend that stringent preventive measures be designed
to control the infectivity and spread of the virus. We also
recommend that other viruses that are known to be associ-
ated with T1DM in children be investigated in the area.
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